Literature DB >> 19240823

Paraneoplastic bleeding disorder due to isolated hypofibrinogenemia: a case report.

Z Cvetkovic1, B Cvetkovic, D Cvetkovic, V Libek, G Perunicic-Pekovic.   

Abstract

An 80 years old male patient was admitted in our hospital with massive haematomas in the left forearm, chest and abdominal wall accompanied by intense back pain symptoms. Laboratory evaluation showed anemia, mild thrombocytopenia and elevated lactate dehydrogenase and alkaline phosphatase levels and normal concentrations of all the other biochemical parameters. Study of the coagulation status demonstrated prolonged thrombin time (TT), low fibrinogen levels--0.98 g/l while plasminogen, antithrombin III (AT III) and protein C levels were found to be within normal range. Computed tomography scans of the head, chest and abdomen showed an enlarged infiltrative prostate, osteolytic bone lesions in vertebras L5-S1 and a large haematoma of the abdominal wall as the only pathologic findings. Very high levels of the prostate specific antigen indicated the possible existence of a prostate carcinoma with metastases to the vertebral column that resulted in elevated alkaline phosphate and lactate dehydrogenase levels. There were no signs of liver involvement and impaired hepatic synthetic function. Based on the results of the laboratory tests we concluded that the cause of the bleeding disorder in our patient was an acquired hypofibrinogenemia, which is a very rare paraneoplastic phenomenon. The patient was treated with daily transfusions of cryoprecipitate with no long-term improvement. Then the specific anti-tumor therapy (ciproteron acetate) was initiated, and two weeks later, fibrinogen concentration and TT returned to normal values.

Entities:  

Keywords:  bleeding disorder; cancer; fibrinogen

Year:  2009        PMID: 19240823      PMCID: PMC2633255     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  16 in total

Review 1.  HEMORRHAGE AND THROMBOSES ASSOCIATED WITH NEOPLASTIC DISORDERS.

Authors:  M C ROSENTHAL; J NIEMETZ; N WISCH
Journal:  J Chronic Dis       Date:  1963-07

2.  Hypofibrinogenemia induced by prednisolone therapy in a patient with chronic lymphocytic leukemia complicated with autoimmune hemolytic anemia.

Authors:  N Yokose; K Ogata; K Nakamura; K Kamikubo; H Tamura; E An; K Dan; T Nomura
Journal:  Am J Hematol       Date:  1997-07       Impact factor: 10.047

3.  Hypofibrinogenemia in an individual with 2 coding (gamma82 A-->G and Bbeta235 P-->L) and 2 noncoding mutations.

Authors:  S O Brennan; A P Fellowes; J M Faed; P M George
Journal:  Blood       Date:  2000-03-01       Impact factor: 22.113

4.  Disseminated intravascular coagulation in solid tumors: clinical and pathologic study.

Authors:  S Sallah; J Y Wan; N P Nguyen; L R Hanrahan; G Sigounas
Journal:  Thromb Haemost       Date:  2001-09       Impact factor: 5.249

5.  Acute disseminated intravascular coagulation syndrome in cancer patients.

Authors:  E Pasquini; L Gianni; E Aitini; M Nicolini; P P Fattori; G Cavazzini; F Desiderio; F Monti; M E Forghieri; A Ravaioli
Journal:  Oncology       Date:  1995 Nov-Dec       Impact factor: 2.935

6.  [Analysis of hypofibrinogenemias found on routine coagulation screening tests and identification of heterozygous dysfibrinogenemia or fibrinogen deficiency].

Authors:  Masako Hirota-Kawadobora; Shinsuke Ishikawa; Noriko Fujihara; Saki Wakabayashi; Yuka Kamijo; Kazuyoshi Yamauchi; Fumiko Terasawa; Nobuo Okumura; Tsutomu Katsuyama
Journal:  Rinsho Byori       Date:  2007-11

7.  Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis.

Authors:  A Weltermann; I Pabinger; K Geissler; U Jäger; H Gisslinger; P Knöbl; S Eichinger; P A Kyrle; P Valent; W Speiser; I Schwarzinger; C Mannhalter; K Lechner
Journal:  Leukemia       Date:  1998-08       Impact factor: 11.528

8.  Cryoprecipitate. Patterns of use.

Authors:  Liron Pantanowitz; Margot S Kruskall; Lynne Uhl
Journal:  Am J Clin Pathol       Date:  2003-06       Impact factor: 2.493

9.  An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.

Authors:  Michael B Jordan; David Hildeman; John Kappler; Philippa Marrack
Journal:  Blood       Date:  2004-04-06       Impact factor: 22.113

Review 10.  Molecular mechanisms accounting for fibrinogen deficiency: from large deletions to intracellular retention of misfolded proteins.

Authors:  D Vu; M Neerman-Arbez
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.